Gapping up
In reaction to strong earnings/guidance:
In reaction to strong earnings/guidance:
- ON +7.9%, VSM +4.8%, TSEM +3.7%, TEVA +3.6%, NSP +2.9%, FDC +2.4%, QSR +1.6%, WEX +0.6%
M&A news:
- ELOS +4.3% (in talks to be acquired by Apax Partners, according to Calcalist)
Select metal producer stocks trading higher:
- VALE +4.9%, MT +4.8%, X +2.4%, CLF +2.4%, FCX +1.6%, RIO +1.6%, BBL +1.5%, BHP +1.1%
Other news:
- IMMU +7.8% (venBio comments on Immunomedics partnership announcement with Seattle Genetics (SGEN))
- PLUG +7.6% (continued strength following Firday's move)
- INO +7.5% (enters into a collaboration and license agreement providing ApolloBio with the exclusive right to develop and commercialize VGX-3100 within Greater China)
- AXON +4.6% (announces preliminary results from the planned interim analysis of the first 11 patients to complete its Phase 2 study of nelotanserin)
- SHLD +2% (continued strength following Friday's move higher)
- M +1.8% (Barron's profiles positive view on Macy's)
- MYL +1.6% (in sympathy with TEVA)
- PRGO +1.3% (in sympathy with TEVA)
- PSTI +0.9% (provides clinical updates; study initiation of the pivotal Phase III trial in CLI received clearance from regulatory authorities in the US, UK, and Germany)
Analyst comments:
- CMRE +4.7% (upgraded to Outperform from Market Perform at Wells Fargo)
- JCP +2.2% (upgraded to Equal-Weight from Underweight at Morgan Stanley)
- PBR +1.8% (upgraded to Overweight from Neutral at JP Morgan)